Switzer TV

Markets are volatile, tech stocks have been sold off, and banks and miners have led recent gains. And yet, the ASX200 continues to flirt with a new record of over 9000!

On this week’s Switzer Investing TV, Peter Switzer speaks with Jun Bei Liu of Ten Cap and Paul Rickard about how they would position portfolios.

The discussion covers recent moves in Xero, WiseTech and Life360, the outlook for CSL and Cochlear, and whether JB Hi-Fi and James Hardie offer value after sharp share price swings.

They also examine the resilience of the banks, the impact of AI fears on growth stocks, and what earnings season is revealing about market confidence.

Watch the full episode for the latest insights on how experienced investors are navigating the current volatility.

What top stock pickers are buying in this chaotic market (Switzer Investing TV 16/02/25)

Markets are volatile, tech stocks have been sold off, and banks and miners have led recent gains. And yet, the ASX200 continues to flirt with a new record of over 9000!

More videos

Mad about Money Live

Tune in to the latest live episode of Mad about Money with Peter Switzer and Paul Rickard.

Series:
3 hot value stocks + CEO of iSelect, buy or not & house price boom to die?

Roger Montgomery from Montgomery Investment Management, Warren Hebard from iSelect, Michael Knox from Morgans and Paul Rickard from Switzer join the show.

Series:
Mad about Money Live

Join Peter Switzer and Paul Rickard for the latest live episode of Mad about Money.

Series:
It’s time to hunt for value stocks, try these: CSL, RMD, BHP, WPL + BHP a buy?

Peter Switzer speaks to Julia Lee from Burman Invest, Adam Dawes from Shaw and Partners, Michael Gable from Fairmont Equities and Paul Rickard from Switzer.

Series:
Basal cancer and the treatments that have risen due to COVID-19

Dr Ross Walker discusses research on basal cell cancer treatment that is similar to the COVID-19 vaccine.

Series:
6 top stocks from fund manager and broker + house price boom exaggerated?

Prime Value Asset Management's ST Wong, Morgans' Raymond Chan, Century 21's Charles Tarbey and Coolabah Capital's Ying Yi Ann Cheng join Peter Switzer.

Series:
Mad about Money Live

Peter Switzer and Paul Rickard discuss the big money stories of the day and how they will affect you.

Series:
Graham Kelly from Noxopharm Limited (ASX:NOX)

Peter Switzer speaks to Graham Kelly, the founder, CEO and managing director of Noxopharm (NOX).

Series:
Stocks being dumped that are long term buys: CSL, DMP, JBH & 4 great income stocks

Burman Invest's Julia Lee, Tribeca's Jun Bei Liu, Switzer's Paul Rickard and Spacetalk's Mark Fortunatow join the show.

Series:
The benefits of drinking coffee and tea every day

Last week Dr Ross told us what happens when diabetics have coffee and tea every day, but what are the benefits for non-diabetics?

Series:
Hot tech stocks – MP1, NXL + could stocks fall 10%? & CEO of Aussie Home Loan

Peter Switzer is joined by Michael Wayne from Medallion Financial Group, Kieran Davies from Coolabah Capital and James Symond from Aussie Home Loans.

Series:
Mad about Money Live

Join Peter Switzer and Paul Rickard for our latest live episode of Mad about Money.

Series:
1 33 34 35 36 37 51

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram